Cancer Pharmacology and Preclinical Therapeutics Program
The Cancer Pharmacology and Preclinical Therapeutics Program is a basic science Program that unites investigators with broad scientific expertise who share a strong interest in cancer pharmacology and preclinical drug development to create more effective cancer treatments.
- To discover, design, and develop new anticancer agents.
- To determine the mode of action of and the mechanism of resistance to anticancer agents.
To develop novel concepts and strategies for cancer treatment.